The Emerging Role of the Gut-Brain-Microbiota Axis in Neurodevelopmental Disorders

Area of Science:

• Neuroscience
• Gastroenterology
• Microbiology

Background:

• Autism spectrum disorder (ASD) is a neurodevelopmental disorder frequently associated with gastrointestinal (GI) symptoms.
• The gut-brain axis plays a crucial role in regulating GI function, and alterations in this communication are implicated in ASD.
• Dysfunction in the enteric nervous system and gut microbiome are hypothesized contributors to GI issues in ASD.

Purpose of the Study:

• To investigate the impact of a specific neuroligin-3 (NL3) mutation (R451C), associated with ASD, on gut function and host-microbe interactions.
• To explore neuro-inflammation and microbial dysbiosis in a preclinical model of ASD.

Main Methods:

• Utilized NL3^R451C mutant mice, a model for ASD-associated neuroligin mutations.
• Assessed colonic motility and small intestinal transit.
• Examined macrophage morphology in gut-associated lymphoid tissue.
• Analyzed fecal microbial composition in mice housed in a shared environment.

Main Results:

• NL3^R451C mice exhibited altered colonic motility and accelerated small intestinal transit.
• Macrophage morphology in the gut-associated lymphoid tissue was altered, suggesting neuro-inflammation.
• Fecal microbial dysbiosis was observed in NL3^R451C mice, indicating nervous system influence on gut microbiota.

Conclusions:

• The NL3^R451C mutation leads to significant GI dysfunction and neuro-inflammation in mice.
• These findings highlight the role of the nervous system in regulating the gut microbiome and suggest potential therapeutic targets for ASD-related GI issues.
• Further research comparing clinical and animal model dysbiosis is needed for personalized microbial therapies.